). These results suggest that Cdks can block the formation of pre-RCs ORC complex, Orp1 and Orp2, were C-terminally tagged at their chromosomal locus with three tandem haemagby multiple mechanisms. However, neither these nor previous studies distinguish whether phosphorylation glutinin (HA) epitopes. After crosslinking with formaldehyde, cell lysates were prepared and sonicated to shear of pre-RC components dictates the periodic formation of prereplicative complexes, or the preservation of cell the chromosomal DNA to 500-700 bp fragments. After immunoprecipitation of tagged proteins with an anti-HA ploidy, or both. Cdks have been reported to interact with the N terminus of Cdc18(CDC6) when immunopreantibody, associated chromosomal DNA was amplified using sets of oligos that recognize successive ‫003ف‬ bp cipitated from soluble extracts of cells in which Cdc18(CDC6) is overexpressed and with Orc2 by twosegments across the ARS2004 locus. We found that both Orp1 and Orp2 specifically bind to the region of hybrid analysis or when cooverexpressed in insect cells (Leatherwood et Figure 1B) . They also bound to other replication origins, including ARS1 sive rounds of S phase without an intervening mitosis. Importantly, in these rereplicating cells, all origins are (see below). We noted that the strength of Orp1, Orp2, and Cdc13 binding showed some correlation with the coordinately and periodically licensed and replicated with the same timing as in a normal cell cycle. In this frequency of origin use, suggesting a functional relationship between ORC and Cdc13 at origins ( Figure 1B ). In respect we have been able to experimentally distinguish the molecular mechanisms that impose the global defission yeast, the major cyclin-dependent kinase, Cdc2, binds not only Cdc13 but at least three other cyclins, pendency of S phase on mitosis from controls that ensure the correct order and timing of origin licensing and Cig1, Cig2, and Puc1, which have an overlapping role in the initiation of S phase (Fisher and Nurse, 1996) . We replication prior to and during each successive S phase. Furthermore, we show that stable association of mitotic found using specific antibodies that Cdc2 but not the Cig1, Cig2, or Puc1 cyclins bound ARS2004 in log phase Cyclin B/Cdc2 kinase to replication origins is responsible for ensuring that a subsequent round of S phase is cultures ( Figure 1C Cdc2 complex, the ability of Cdc13 to associate with These are composed of adenine-and thymidinereplication origins was examined in cells bearing a temenriched regions of DNA clustered within a 1-2 kb region perature-sensitive orp1-4 mutation. Although Cdc13 of DNA. The most efficient of these, ARS2004 and bound ARS2004 at the permissive temperature, binding ARS3002, are utilized as replication origins in almost was reduced by 80% after 30 min incubation at the every cell cycle and bind components of both the ORC restrictive temperature in orp1-4 cells, but not in the and MCM complexes. Although ORC binds constituwild-type control culture ( Figure 1F ). Loss of Cdc13 astively to chromatin throughout the fission yeast cell cysociation was not due to proteolytic destruction of cle, the prereplicative complex only forms on origins in Cdc13 as cells accumulated in G1, since orp1-4 cells G1. We postulated that a factor may stably bind ORC retained a 2C DNA during this procedure (data not during G2 and early M phase to prevent reinitiation of shown). A similar ORC dependence was observed in S phase. We reasoned that such a factor might be identitemperature-sensitive orp2-2 cells (data not shown ). Importantly, no spontaneous diploidization or loss of Cdc13 binding to replication ures 3C and 3D). These data suggest that association of the mitotic Cyclin B/Cdc2 kinase with replication oriorigins was observed in orp2-T4A cells, in which all four Cdk-consensus sites had been mutated to nongins in G1 prevents replication licensing and the onset of S phase. Since Orp2 was initially identified by twophosphorylatable residues ( Figures 4E and 4F ). This prompted us to examine the ability of orp2-3HA cells hybrid analysis as a protein that interacts with Cdc2, we reasoned it may act as a "docking site" for Cdc13/ to restrain replication licensing. In wild-type cells, high overexpression of cdc18 alone causes constitutive asCdc2 at replication origins. We postulated that cells expressing a mutant Orp2 protein to which Cdc13 is sociation of Mcm4 to replication origins and overreplication, whereas mild overexpression of cdc18 from the unable to bind may be susceptible to chromosomal reduplication. During the course of these experiments, we pREP41 promoter has little or no effect unless cdt1 is simultaneously overexpressed (Nishitani and To examine whether replication origins may be periodically licensed in the absence of Cdc13, cdc2-33 origins in these two situations, cdc13::ura4 nmt41-cdc13 or nmt1-cdc18 cells were grown either in the cdc13::ura4 nmt41-cdc13(LEU2) mcm4-GFP cells were arrested in G1 by nitrogen starvation for 12 hr, refed presence or absence of thiamine ( Figures 5A and 5B) . Since only 10% of exponentially growing cells are in G1, with a nitrogen source at high temperature to inactivate Cdc2, and then released to the permissive temperature. association of Mcm4 to ARS2004 is barely detectable in cdc13::ura4 nmt41-cdc13 cells in the absence of thiaThis procedure allowed cells to undergo a synchronized endoreduplication cycle, as judged by FACS analysis mine or in nmt1-cdc18 in the presence of thiamine, whereas Cdc13 is readily detectable. Suppression of ( Figure 6C ). We found that during the first G1 phase, Figure S1D ). These results lication cycle in fission yeast described here closely resembles the naturally occurring endoreduplication cysuggest that in a normal cell cycle, the Cig2/Cdc2 kinase specifically and transiently binds to the promoters of cles observed in plants, flies, and certain human tissues. Since ORC is constitutively bound to replication ori-MBF-dependent genes in late G1 but not to replication origins. We next examined if Cig2/Cdc2 dictates replicagins throughout the fission yeast cell cycle and Orp2 interacts with Cdc2 by two hybrid analysis, our data tion licensing in the absence of Cdc13. On release of cdc2-33 cdc13::ura4 nmt41-cdc13 cells into a endoresuggest Orp2 provides a docking site for Cdc13/Cdc2 at replication origins (Leatherwood et al., 1996 ; Lygerou duplication cycle, we were also unable to detect association of Cig2 to ARS2004 as Mcm4 dissociated from the and Nurse, 1999). Furthermore, mutational analysis of Cdc2-dependent phosphorylation sites has suggested origin (see Supplemental Figure S2A ), even though Cig2 transiently associated to the cdc18 promoter during this that phosphorylation of Orp2 by Cdc2 contributes to suppression of pre-RC formation during a normal cell period (see Supplemental Figure S2B ). Thus, Cig2/Cdc2 is unlikely to be responsible for the phosphorylation of cycle (Vas et al., 2001) . Importantly, cells that express a mutant Orp2 protein which substantially abrogates Orp2 in the absence of Cdc13. To assess whether Cig2/ Cdc2 may regulate replication licensing by catalyzing binding of Cdc13 to replication origins are acutely prone to diploidization, but this is not observed in cells in which the destruction of nonchromatin bound Cdc18 protein, we examined the expression of Cig2 and Cdc18 during all of the known Cdk phosphorylation sites in Orp2 have been abolished. We propose that ORC bound Cdc13/ an endoreduplication cycle. We found that both cdc18 and cig2 mRNAs and their corresponding proteins are Cdc2 kinase acts locally at the replication origin to prevent pre-RC formation by phosphorylation of additional both periodically expressed in synchronous endoreduplicating cells lacking Cdc13 (see Supplemental Fig- proteins such as Orc6, Cdc18, and possibly other components of the pre-RC complex. To formally verify this ures S2C and S2D). We noted that the Cdc18 protein is degraded and MBF-dependent transcription is repressed prediction, it would be necessary to simultaneously mutate all the phosphorylation sites on each of these procoincidently with the peak of Cig2 protein expression dur- in cdc2-33 and G, ARS3003 by fragments B and C, and ARS3004 by fragments cdc13::ura4 nmt41-cdc13(LEU2) cells. Cells were incubated in mini-H and I. The amplified fragments A to F scanning cdc18 promoter mal medium lacking a nitrogen source for 12 hr to arrest them in region are positioned at the following sites (A from the initial ATG G1. After this time, cells were supplemented with a nitrogen source is ϩ1): fragment A, Ϫ1878 to Ϫ1570; B, Ϫ1187 to Ϫ879; C, Ϫ691 and thiamine to suppress cdc13 expression at 36.5ЊC for 4 hr (from to Ϫ386; D, Ϫ310 to Ϫ5; E, 210 to 524; and F, 903 to 1210. The time Ϫ4 to 0 hr) to arrest them in late G1. At time 0 hr, cells were control fragment 5Ј of cdc18 (cdc18-5Ј) is located at position Ϫ2668 shifted to 25ЊC in the same medium containing thiamine, which led to Ϫ2286, and the control fragment 3Ј of cdc18 (cdc18-3Ј) at position to rapid and synchronous entry into S phase (S phase was com-3771 to 4050. The amplified fragment for cig2 promoter is positioned pleted after 1 hr). At time 1 hr, cells were shifted back to 36.5ЊC for at Ϫ1497 to Ϫ1177 from the ATG. Cdt1 promoter fragment is located 2 hr (from time 1 hr to 3 hr) and then incubated at 25ЊC, which at position Ϫ380 to Ϫ63 from the ATG. induced a second round of S phase.
Mutually Exclusive Association of

Northern Analysis Construction of orp2-3HA Allele
Northern assays were performed as previously described (Aves et al., Three copies of the haemagglutinin (HA) epitope and the kanamycin 1985). For detecting cdc18 mRNA, the Northern blot was probed with drug resistance gene were introduced at the C terminus of the a PCR fragment (1200 to 1582) of cdc18 ORF. The probe for detecting orp2 gene by homologous recombination using a standard protocol cig2 mRNA was a PCR fragment covering the entire cig2 ORF. available at http://pingu.salk.edu/users/forsburg/vectors.html.
In Situ Chromatin Binding Assay for Mcm4-GFP Biochemistry
In situ chromatin binding assay for Mcm4-GFP was as previously Western blots were performed as previously described ( 
